All Segments
Big Ideas in 2024: Democratizing “Miracle Drugs” with Julie Yoo
8 segments available
In 2023, a wave of therapies hailed as miracle drugs — including GLP-1’s and curative cell and gene therapies — had a profound impact in patients’ lives. With 3.6 million prescription claims for GLP-1s in 2022, the question arises: Can innovators establish a sustainable approach to bring these groundbreaking drugs to market without causing financial strain or system breakdown? Julie Yoo, General Partner at Andreessen Horowitz, shares a compelling big idea for 2024: Democratizing “Miracle Drugs”. Timecodes: 00:00 - Big Ideas in Tech 2024 01:39 - Democratizing “Miracle Drugs” 02:35 - How a GPL-1 works and the potential impact of the drug 08:32 - Curative cell and gene therapies 11:21 - Drug costs and insurance systems 15:16 -The changes needed to enable drug access 17:36 - What solutions are being built? 20:48 - Policy, the FDA, and CMS Resources: View all 40+ big ideas: https://a16z.com/bigideas2024 Find Julie on X: https://twitter.com/julesyoo Stay Updated: Find a16z on Twitter: https://twitter.com/a16z Find a16z on LinkedIn: https://www.linkedin.com/company/a16z Subscribe on your favorite podcast app: https://a16z.simplecast.com/ Follow our host: https://twitter.com/stephsmithio Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
Segments Timeline
Big Ideas in Tech 2024
Julie Yoo introduces the concept of democratizing miracle drugs as part of the big ideas for 2024. She highlights the importance of addressing the challenges and opportunities in the healthcare system to bring innovative therapies to market without financial strain.
"Precision delivery of medicine entertainment franchise games absolutely exploding small modul reactors and the nuclear Renaissance plus AI moving into very complex workflows now these were just a few ..."
Democratizing Miracle Drugs
Julie Yoo discusses the profound impact of therapies like GLP-1s and gene therapies on patients' lives. She emphasizes the need for innovation at the intersection of policy, biopharmaceutical manufacturing, and clinical operations to ensure these therapies are accessible without breaking the healthcare system.
"in as a reminder the content here is for informational purposes only should not be taken as legal business tax or investment advice or be used to evaluate any investment or security and is not directe..."
Understanding GLP-1s
Julie explains how GLP-1s work, their role in managing blood sugar levels, and their initial use in treating type 2 diabetes. She highlights the growing popularity of these drugs due to their weight loss effects and discusses their societal impact on obesity, which affects over 42% of Americans.
"like this will be a rarity but for listeners who may be unfamiliar let's start with gp1s why are people touting these as Miracle drugs yes so gp1s aren all the rage as you're implying um but uh so the..."
Curative Cell and Gene Therapies
Julie delves into the realm of curative cell and gene therapies, explaining how they can address genetic diseases and potentially eradicate them. She discusses the complexities and costs associated with these therapies, emphasizing the need for a healthcare system that can accommodate such innovations.
"and the clinical burden um to our current Healthcare System so um there are many you know chronic or fatal diseases that stem from uh genetic code mishaps so you might be born with a gene mutation uh ..."
Drug Costs and Insurance Systems
Julie addresses the challenges posed by the current healthcare insurance system in covering the costs of innovative therapies like GLP-1s. She highlights the disparity between the number of eligible patients and those who can access these drugs due to insurance limitations and high costs.
"kind of drugs that we've always wanted right we've always wished for you use the term Miracle drugs so why is it that our Health Care system isn't really poised to cushion the introduction of these dr..."
Necessary Changes for Drug Access
Julie discusses the systemic changes needed to enable broader access to miracle drugs. She emphasizes the importance of innovative financing mechanisms and the need for healthcare providers to adapt to the complexities of administering these therapies.
"gp1s a little bit there just in terms of the therapies that you just mentioned are Curative and that introduces all types of questions around like what is a life worth and you know like who like you s..."
Innovative Solutions in Healthcare
Julie highlights the entrepreneurial efforts underway to address the challenges of bringing miracle drugs to market. She discusses innovations in manufacturing, logistics, and data collection that aim to improve patient access and outcomes in the healthcare system.
"seeing built maybe what also roadblocks do you expect on the on the road to implementing some of these changes and also where do you think policy might play a role what do you see really coming in 202..."
Policy and the Future of Drug Access
Julie concludes by discussing the role of policy in shaping the future of drug access. She emphasizes the need for regulatory changes from bodies like the FDA and CMS to facilitate the introduction of innovative therapies while ensuring patient safety and affordability.
"able to basically thread that needle and ensure that people who need these drugs get them or coming back to that question around policy do you think that there needs to to be a role played there which..."